{"PubmedArticle": [{"MedlineCitation": {"InvestigatorList": [], "SpaceFlightMission": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "OtherID": [], "PMID": "22392778", "DateCompleted": {"Year": "2012", "Month": "08", "Day": "01"}, "DateRevised": {"Year": "2013", "Month": "11", "Day": "21"}, "Article": {"Language": ["rus"], "ELocationID": [], "ArticleDate": [], "Journal": {"ISSN": "1512-0112", "JournalIssue": {"Issue": "202", "PubDate": {"Year": "2012", "Month": "Jan"}}, "Title": "Georgian medical news", "ISOAbbreviation": "Georgian Med News"}, "ArticleTitle": "[Impact of new technologies on the rheological properties of blood in plastic surgery of the breast].", "Pagination": {"StartPage": "22", "EndPage": "28", "MedlinePgn": "22-8"}, "Abstract": {"AbstractText": ["151 patients were examined undergoing breast reconstruction. In all patients after surgery were studied rheology and acid ground state of the blood. Of these 71 patients was performed ozone therapy. This use ozone therapy helps oxygen supple of tissues, a significant decrease in lymphostasis upper limb, increases the oxygen tension in the tissues and blood, normalizes blood flow, more rapidly restores blood lymph and is the prevention postoperative complications. Frequency of early postoperative complications decreased 2,5 times the number of necrotic autotransplantate--5 times compared with patients who are in post-operative fluid therapy did not include ozone-oxygenated crystalloid solutions."]}, "AuthorList": [{"AffiliationInfo": [], "Identifier": [], "LastName": "Alekberov", "ForeName": "D G", "Initials": "DG"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Potanin", "ForeName": "V P", "Initials": "VP"}], "PublicationTypeList": ["English Abstract", "Journal Article"]}, "MedlineJournalInfo": {"Country": "Georgia (Republic)", "MedlineTA": "Georgian Med News", "NlmUniqueID": "101218222", "ISSNLinking": "1512-0112"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Biocompatible Materials"}, {"RegistryNumber": "0", "NameOfSubstance": "Hemoglobins"}, {"RegistryNumber": "66H7ZZK23N", "NameOfSubstance": "Ozone"}, {"RegistryNumber": "9001-32-5", "NameOfSubstance": "Fibrinogen"}], "MeshHeadingList": [{"QualifierName": ["adverse effects"], "DescriptorName": "Biocompatible Materials"}, {"QualifierName": ["drug effects"], "DescriptorName": "Blood Viscosity"}, {"QualifierName": ["surgery"], "DescriptorName": "Breast Neoplasms"}, {"QualifierName": ["drug effects"], "DescriptorName": "Erythrocyte Deformability"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": ["metabolism"], "DescriptorName": "Fibrinogen"}, {"QualifierName": ["metabolism"], "DescriptorName": "Hemoglobins"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Mammaplasty"}, {"QualifierName": ["administration & dosage"], "DescriptorName": "Ozone"}, {"QualifierName": [], "DescriptorName": "Postoperative Period"}, {"QualifierName": ["adverse effects"], "DescriptorName": "Surgery, Plastic"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2012", "Month": "3", "Day": "7", "Hour": "6", "Minute": "0"}, {"Year": "2012", "Month": "3", "Day": "7", "Hour": "6", "Minute": "0"}, {"Year": "2012", "Month": "8", "Day": "2", "Hour": "6", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["22392778"]}}], "PubmedBookArticle": []}